Trial Outcomes & Findings for The Computed Tomography-derived Fractional Flow Reserve STAT Trial (NCT NCT03263806)

NCT ID: NCT03263806

Last Updated: 2018-07-03

Results Overview

Percent of patients undergoing heart catheterization

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

13 participants

Primary outcome timeframe

3 months after initial presentation

Results posted on

2018-07-03

Participant Flow

Emergency department patients who had a Cardiac CT scan, were screened for the study. The doctors interpreting the CT scan notifies the research coordinator regarding potential eligibility of the patient to the study.

Participant milestones

Participant milestones
Measure
SOC Group Management
Attending physicians will dictate SOC management according to their own clinical judgment for medical management, stress test plus imaging or coronary artery catheterization with invasive fractional flow reserve. SOC Group Management: Patients will receive standard of care CT on enrollment which will be analyzed by CTFFR. Results are NOT communicated to the provider who will dictate patient management according to their own clinical judgment
CTFFR-Guided Group Management
Patients in this group will be triaged using CTFFR. CTFFR values will be provided to physicians with recommendations for medical management or coronary artery catheterization with invasive fractional flow reserve. CTFFR-Guided Group Management: Patients will receive standard of care CT on enrollment which will be analyzed by CTFFR. Results will be communicated to the provider who will use CTFFR interpretation to guide care pathway.
Overall Study
STARTED
6
7
Overall Study
COMPLETED
0
0
Overall Study
NOT COMPLETED
6
7

Reasons for withdrawal

Reasons for withdrawal
Measure
SOC Group Management
Attending physicians will dictate SOC management according to their own clinical judgment for medical management, stress test plus imaging or coronary artery catheterization with invasive fractional flow reserve. SOC Group Management: Patients will receive standard of care CT on enrollment which will be analyzed by CTFFR. Results are NOT communicated to the provider who will dictate patient management according to their own clinical judgment
CTFFR-Guided Group Management
Patients in this group will be triaged using CTFFR. CTFFR values will be provided to physicians with recommendations for medical management or coronary artery catheterization with invasive fractional flow reserve. CTFFR-Guided Group Management: Patients will receive standard of care CT on enrollment which will be analyzed by CTFFR. Results will be communicated to the provider who will use CTFFR interpretation to guide care pathway.
Overall Study
Elevated Troponin (failed screen)
1
0
Overall Study
Withdrawal by Subject
0
1
Overall Study
Study Termination
5
6

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
SOC Group Management
n=5 Participants
Attending physicians will dictate SOC management according to their own clinical judgment for medical management, stress test plus imaging or coronary artery catheterization with invasive fractional flow reserve. SOC Group Management: Patients will receive standard of care CT on enrollment which will be analyzed by CTFFR. Results are NOT communicated to the provider who will dictate patient management according to their own clinical judgment
CTFFR-Guided Group Management
n=6 Participants
Patients in this group will be triaged using CTFFR. CTFFR values will be provided to physicians with recommendations for medical management or coronary artery catheterization with invasive fractional flow reserve. CTFFR-Guided Group Management: Patients will receive standard of care CT on enrollment which will be analyzed by CTFFR. Results will be communicated to the provider who will use CTFFR interpretation to guide care pathway.
Total
n=11 Participants
Total of all reporting groups
Age, Continuous
52 years
n=5 Participants
60.5 years
n=6 Participants
57 years
n=11 Participants
Sex: Female, Male
Female
3 Participants
n=5 Participants
2 Participants
n=6 Participants
5 Participants
n=11 Participants
Sex: Female, Male
Male
2 Participants
n=5 Participants
4 Participants
n=6 Participants
6 Participants
n=11 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
5 Participants
n=5 Participants
6 Participants
n=6 Participants
11 Participants
n=11 Participants

PRIMARY outcome

Timeframe: 3 months after initial presentation

Population: Study terminated with NO data collected.

Percent of patients undergoing heart catheterization

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3 months after initial presentation

Population: Study terminated with NO data collected.

Proportion of accurate triage using FFR measured at heart catheterization (CATH-FFR) among all patients triaged to heart catheterization by each strategy

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 1 year after presentation

Population: Study terminated with NO data collected.

Incidence of any serious adverse event, defined as death, acute coronary syndrome or late unscheduled revascularization

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: An average of 2 days

Population: Study terminated with NO data collected.

Time from admission to discharge from hospital in days

Outcome measures

Outcome data not reported

Adverse Events

SOC Group Management

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

CTFFR-Guided Group Management

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Korana Stakich-Alpirez

Beaumont Hospitals

Phone: 248 898 0315

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place